Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

Conditions

• Amyotrophic Lateral Sclerosis (ALS)

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Video recording — BEHAVIORAL
  We will video record participants' multidisciplinary clinic (MDC) visits for 12 months. Participants will access the videos in HealthPAL, an NIH-funded, HIPAA-compliant personal health library developed with older adults and caregivers, available in Spanish and English. Each specialist visited with during the MDC will have a 'chapter' in HealthPAL that can be reviewed online at home by participants. Participants will receive orientation and training on both their patient portal and HealthPAL, including how to review and share their recordings using a take-home manual (an instructions video is also available in HealthPAL).
• Notes Instruction — BEHAVIORAL
  Participants will be given instruction on how to view their after-visit summaries and doctors' notes in their patient portal, as well as how to give other trusted family members or friends access to their visit notes.

Study Details

Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). In these multidisciplinary clinics, which occur every 3 to 4 months, people with ALS see up to 12 different healthcare providers (e.g., speech therapy, physical therapy, the ALS doctor). These clinics can last from three to five hours, and across these three to five hours people with ALS and their caregivers receive a lot of information that is critical to the care and quality of life for people with ALS. However, this information can be difficult to remember given the large amount of information that is conveyed. The current standard for providing take-home information about the visit is to provide patients with a written after-visit summary and access to their doctor's notes about the visit, typically through the patient portal. This study tests whether providing participants with video recordings of their MDC visits improves their quality of life and the quality of life of their caregivers. The study will enroll 400 pairs of people with ALS and their caregivers from eight different sites in the United States. Half of the participants in the study will receive their after-visit summary notes (the NOTES condition) and the other half of the participants will receive both their summary notes, but will also receive video recordings of their MDC visits that they can watch on their own at home (the VIDEO condition). The study will last for 12 months, with participants receiving NOTES or VIDEO at each of their regularly-scheduled MDCs during the 12 months. The study will test whether caregiver and patient participants in the VIDEO condition experience better quality of life than those in the NOTES condition at 1 month, 6 months, and 12 months from study enrollment. The results of this study will help determine what is the most effective approach to communicating MDC information to people with ALS and their caregivers.

Key Dates

Start date

Jun 1, 2026

Status verified

Feb 2026

Primary completion

Sep 1, 2029

Completion

Oct 1, 2029

Study Design

Enrollment

800 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Arms

• Experimental: VIDEO
  Participants in this arm of the study will have their multidisciplinary clinic visits video recorded and they will be able to access those video recordings on their own at home. They will also be able to access their doctor's notes and after visit summaries through their patient portal.
• Active Comparator: NOTES
  Participants in this arm of the study will have their standard access to their doctor's notes and after visit summaries through their patient portal. They will also be provided with training on how to access and share access to their patient portal notes.

Primary Outcome Measure

For Caregiver Participants: the total score on the PROMIS-10 self report survey [ Time Frame: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment. ]

Central Contacts

• Paul J Barr, PhD
  603-646-7016
  [email protected]
• Kelly M Goedert, PhD
  603-646-6976
  [email protected]

Locations (7)

Find similar trials in Scottsdale, AZ

Related Studies

• Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
  PHASE1/PHASE2 · Recruiting · Ashvattha Therapeutics, Inc. · San Francisco, California
• Safety Study of XT-150 in Participants With ALS
  PHASE1 · Not Yet Recruiting · Xalud Therapeutics, Inc. · Phoenix, Arizona
• Control of Assistive Devices Via Brain-Computer Interface Technology
  Enrolling By Invitation · Neuralink Corp · Phoenix, Arizona
• Examining Interactions Between PALS and Caregivers
  Recruiting · Penn State University · University Park, Pennsylvania